Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months Date Wednesday, November 03, 2021 - 6:00 PM Description
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race Date Wednesday, November 03, 2021 - 6:00 PM Description
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum Date Wednesday, November 03, 2021 - 8:00 AM Description
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge Date Wednesday, November 03, 2021 - 8:00 AM Description
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis Date Wednesday, October 27, 2021 - 6:00 PM Description
Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America Date Wednesday, October 27, 2021 - 6:00 PM Description
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk Date Wednesday, October 27, 2021 - 6:00 PM Description